Download presentation
Presentation is loading. Please wait.
1
Volume 10, Issue 5, Pages 967-972 (November 2004)
AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study Arto Immonen, Matti Vapalahti, Kristiina Tyynelä, Heleena Hurskainen, Anu Sandmair, Ritva Vanninen, Gillian Langford, Neil Murray, Seppo Ylä-Herttuala Molecular Therapy Volume 10, Issue 5, Pages (November 2004) DOI: /j.ymthe Copyright © 2004 The American Society of Gene Therapy Terms and Conditions
2
FIG. 1 Survival of Adv.HSV-tk treated patients and randomised controls. (A) All patients. (B) Patients with glioblastoma multiforme. Kaplan–Meier plots with log rank regression analysis. Molecular Therapy , DOI: ( /j.ymthe ) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions
3
FIG. 2 Survival of Adv HSV-tk-treated patients and historical controls. (A) All patients. (B) Patients with glioblastoma multiforme. Kaplan–Meier plots with log rank regression analysis. Molecular Therapy , DOI: ( /j.ymthe ) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.